# Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC)

> **NCT01326559** · PHASE2 · COMPLETED · sponsor: **Hong Kong Nasopharyngeal Cancer Study Group Limited** · enrollment: 33 (actual)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **DRUG:** Docetaxel, Cisplatin, 5-FU and Cetuximab

## Key facts

- **NCT ID:** NCT01326559
- **Lead sponsor:** Hong Kong Nasopharyngeal Cancer Study Group Limited
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2016-12
- **Final completion:** 2017-03
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2017-08-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01326559

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01326559, "Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC)". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT01326559. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*